Cheryl Xu
Vermögen: 5 259 $ am 30.09.2026
Vermögen: 5 259 $ am 30.09.2026
Cheryl Xu is currently Director at 60 Degrees Pharmaceuticals, Inc. since 2023.
Formerly, Ms. Xu was Director-International Finance at Pharmacia Corp.
and Vice President-Public Policy & Government Affairs at Biogen, Inc. Ms. Xu earned an MBA from the University of Washington and completed undergraduate studies at Peking University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.07.2026 | 3.954 ( 0,11 % ) | 5 259 $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| 60 DEGREES PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 11.07.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01.03.2023 |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Finanzdirektor/CFO | 28.03.2013 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
60 Degrees Pharmaceuticals, Inc.
60 Degrees Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for infectious diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen